Ferring leaders: SVP R&D Supervisor Alan Harris, China CEO Jan Peutzfeldt, VP Therapeutic Area Head Reproductive Medicine & Women's Health Research Marcel van Duin, Reproductive Health Supervisor Ian Cottingham, VP Translational Medicine Malin Carlsson, VP Bioanalysis Karsten Skydsgaard, China Innovation Director Donghui Qin, and Corporation attorney Bolette Wildt visited the SRLab accompanied by Prof. Hongmei Wang, Prof. Haoyi Wang and met CAS VP Yaping Zhang. 

On behalf of the Chinese Academy of Sciences (CAS), Zhang Yaping fully affirmed and highly evaluated the extraordinary achievements by the SRLab and its leading role in the field of reproductive biology. Zhang encouraged the collaboration of the SRLab with international competitive pharmaceutical companies like Ferring Pharmaceuticals to advance translational research and resolve global reproductive health problems. 

Yaping Zhang Meets Ferring Pharmaceuticals on 7 Jun 2017.